ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

NCT02048059 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Brain Metastases

Interventions

DRUG: ANG1005

Sponsor

Angiochem Inc